Literature DB >> 21670604

Spinophilin loss contributes to tumorigenesis in vivo.

Irene Ferrer1, Sandra Peregrino, Marta Cañamero, Yolanda Cecilia, Carmen Blanco-Aparicio, Amancio Carnero.   

Abstract

The scaffold protein spinophilin (SPN, PPP1R9B) is a regulatory subunit of phosphatase-1a located at 17q21.31. This region is frequently associated with microsatellite instability and LOH and contains a relatively high density of known tumor suppressor genes (such as BRCA1), putative tumor suppressor genes and several unidentified candidate tumor suppressor genes located distal to BRCA1. Spn is located distal to BRCA1, and we have previously shown that the loss of Spn contributes to human tumorigenesis in the absence of p53 function. In this work, we explore the role of Spn as putative tumor suppressor in in vivo models using genetically modified mice. Spn-knockout mice had decreased lifespan with increased cellular proliferation in tissues such as the mammary ducts and early appearance of tumors, such as lymphoma. Furthermore, the combined loss of Spn and mutant p53 activity led to increased mammary carcinomas, confirming the functional relationship between p53 and Spn. We suggest that Spn may be a novel tumor suppressor located at 17q21.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21670604     DOI: 10.4161/cc.10.12.15798

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  7 in total

1.  MicroRNAs as molecular classifiers for cancer.

Authors:  Aaron J Schetter; Curtis C Harris
Journal:  Cell Cycle       Date:  2011-09-01       Impact factor: 4.534

2.  Loss of the tumor suppressor spinophilin (PPP1R9B) increases the cancer stem cell population in breast tumors.

Authors:  I Ferrer; E M Verdugo-Sivianes; M A Castilla; R Melendez; J J Marin; S Muñoz-Galvan; J L Lopez-Guerra; B Vieites; M J Ortiz-Gordillo; J M De León; J M Praena-Fernandez; M Perez; J Palacios; A Carnero
Journal:  Oncogene       Date:  2015-09-21       Impact factor: 9.867

3.  Low spinophilin expression enhances aggressive biological behavior of breast cancer.

Authors:  Daniela Schwarzenbacher; Verena Stiegelbauer; Alexander Deutsch; Anna Lena Ress; Ariane Aigelsreiter; Silvia Schauer; Karin Wagner; Tanja Langsenlehner; Margit Resel; Armin Gerger; Hui Ling; Cristina Ivan; George Adrian Calin; Gerald Hoefler; Beate Rinner; Martin Pichler
Journal:  Oncotarget       Date:  2015-05-10

4.  Coordinated downregulation of Spinophilin and the catalytic subunits of PP1, PPP1CA/B/C, contributes to a worse prognosis in lung cancer.

Authors:  Eva M Verdugo-Sivianes; Lola Navas; Sonia Molina-Pinelo; Irene Ferrer; Alvaro Quintanal-Villalonga; Javier Peinado; Jose M Garcia-Heredia; Blanca Felipe-Abrio; Sandra Muñoz-Galvan; Juan J Marin; Luis Montuenga; Luis Paz-Ares; Amancio Carnero
Journal:  Oncotarget       Date:  2017-10-26

5.  Mutation of SPINOPHILIN (PPP1R9B) found in human tumors promotes the tumorigenic and stemness properties of cells.

Authors:  Eva M Verdugo-Sivianes; Ana M Rojas; Sandra Muñoz-Galván; Daniel Otero-Albiol; Amancio Carnero
Journal:  Theranostics       Date:  2021-01-19       Impact factor: 11.556

Review 6.  Role of the Holoenzyme PP1-SPN in the Dephosphorylation of the RB Family of Tumor Suppressors During Cell Cycle.

Authors:  Eva M Verdugo-Sivianes; Amancio Carnero
Journal:  Cancers (Basel)       Date:  2021-05-06       Impact factor: 6.639

7.  Low expression of the putative tumour suppressor spinophilin is associated with higher proliferative activity and poor prognosis in patients with hepatocellular carcinoma.

Authors:  A Aigelsreiter; A L Ress; K Bettermann; S Schauer; K Koller; F Eisner; T Kiesslich; T Stojakovic; H Samonigg; P Kornprat; C Lackner; J Haybaeck; M Pichler
Journal:  Br J Cancer       Date:  2013-04-16       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.